DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Fejzo MS, MacGibbon KW, Mullin PM.
Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.
Reprod Toxicol 2016;
62: 87-91
DOI: 10.1016/j.reprotox.2016.04.027.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.